These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 17311521)

  • 1. To the editor: in reply to Nakano et al. Clin Chem Lab Med 2006;44(5):522-532.
    Robson E; Mead G; Bradwell A
    Clin Chem Lab Med; 2007; 45(2):264-5; author reply 266-7. PubMed ID: 17311521
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Vavrova et al. Clin Chem Lab Med 2011;49:89-92.
    Legg A; Hughes R
    Clin Chem Lab Med; 2011 Jul; 49(7):1243-4. PubMed ID: 21619478
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of sample dilution on two free light chain nephelometric assays.
    Jacobs JF; Hoedemakers RM; Teunissen E; van der Molen RG; te Velthuis H
    Clin Chim Acta; 2012 Oct; 413(19-20):1708-9. PubMed ID: 22588162
    [No Abstract]   [Full Text] [Related]  

  • 4. Free light chains.
    Sheldon J
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):503-5. PubMed ID: 17961302
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to the article entitled "Impact of assay design on test performance: lessons learned from 25-hydroxyvitamin D" by Farrell et al., Clin Chem Lab Med 2014;52:1579-87.
    Donnelly J; Freeman J; Wilson K; Shalhoub V; Sibley P
    Clin Chem Lab Med; 2015 Apr; 53(5):e129-30. PubMed ID: 25332295
    [No Abstract]   [Full Text] [Related]  

  • 6. Proposed reference material for human free immunoglobulin light chain measurement.
    Nakano T; Miyazaki S; Shinoda Y; Inoue I; Katayama S; Komoda T; Nagata A
    J Immunoassay Immunochem; 2006; 27(2):129-37. PubMed ID: 16711251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2):205-212.
    Badrick T
    Clin Chem Lab Med; 2023 Jul; 61(8):e135-e136. PubMed ID: 36866704
    [No Abstract]   [Full Text] [Related]  

  • 8. In reply to Tate et al. Clin Chim Acta 2007;376:30-6.
    Robson E; Mead G; Carr-Smith H; Bradwell A
    Clin Chim Acta; 2007 May; 380(1-2):247; author reply 250-1. PubMed ID: 17368602
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Luksic et al. Clin Chem Lab Med 2018;56(4):574-581.
    Vidal-Pla M; San-José P; Aguadero V; Cano-Corres R; García-Humia P; Swadak B; Berlanga-Escalera E
    Clin Chem Lab Med; 2019 Oct; 57(11):e298-e300. PubMed ID: 31112506
    [No Abstract]   [Full Text] [Related]  

  • 10. Hook effect with lambda free light chain in serum free light chain assay.
    Levinson SS
    Clin Chim Acta; 2010 Nov; 411(21-22):1834-6. PubMed ID: 20667445
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to the Letter of Sun et al. [1] relating to Clin Chem Lab Med 2022;60(9):1365-72.
    Smith TP; Fahie-Wilson MN
    Clin Chem Lab Med; 2022 Oct; 60(11):e244-e245. PubMed ID: 36052827
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to Tony Badrick regarding "Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2):205-212 by".
    Dimech WJ; Vincini GA; Plebani M; Lippi G; Nichols JH; Sonntag O
    Clin Chem Lab Med; 2023 Jul; 61(8):e137-e139. PubMed ID: 36872632
    [No Abstract]   [Full Text] [Related]  

  • 14. AL-type amyloidosis and light chain deposition disease.
    Pelegri A; Campo E; Romero R; Reguant M; Aisa L
    Clin Nephrol; 1986 Apr; 25(4):220. PubMed ID: 3084148
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunochemical quantification of free immunoglobulin light chains from an analytical perspective.
    Nakano T; Miyazaki S; Takahashi H; Matsumori A; Maruyama T; Komoda T; Nagata A
    Clin Chem Lab Med; 2006; 44(5):522-32. PubMed ID: 16681419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum free light chains; the need to establish local reference intervals.
    Pattenden RJ; Rogers SY; Wenham PR
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):512-5. PubMed ID: 17961304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species specificity in the isoelectric spectra of immunoglobulin light chains.
    Gibson DM
    J Immunol; 1977 Feb; 118(2):409-11. PubMed ID: 402416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The idiotypes of V kappa 21 light chains.
    Huppi K; Julius M; Staudt L; Gerhard W; Weigert M
    Ann Immunol (Paris); 1984; 135C(1):181-5. PubMed ID: 6424552
    [No Abstract]   [Full Text] [Related]  

  • 19. Free light chains of immunoglobulins in normal serum and urine determined by radioimmunoassay.
    Sölling K
    Scand J Clin Lab Invest; 1975 Sep; 35(5):407-12. PubMed ID: 810881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of free light chains in biological fluids by a latex test].
    Ciaiolo C; Ciapini A; Plos R; Marletto G
    Minerva Med; 1991 Jun; 82(6):409-14. PubMed ID: 1906151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.